1. Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer
    Takahisa Yamaguchi et al, 2017 CrossRef
  2. Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway
    TOSHIFUMI SHINBO et al, 2015 CrossRef
  3. CXCR4 blockade with AMD3100 enhances Taxol chemotherapy to limit ovarian cancer cell growth
    Patrick M. Reeves et al, 2017, Anti-Cancer Drugs CrossRef
  4. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells.
    Manish Kumar Pal et al, 2016, Eur J Pharmacol CrossRef
  5. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast
    Hiroto Saito et al, 2018, Gastric Cancer CrossRef
  6. Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.
    Liyu Chen et al, 2015, Oncol Lett CrossRef
  7. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc
    Maha H. Sharawy et al, 2018, Life Sciences CrossRef
  8. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    T Yoshida et al, 2014, Br. J. Cancer CrossRef
  9. Epithelial–mesenchymal transition in the formation of hypertrophic scars and keloids
    Feng‐Lai Yuan et al, 2019, J Cell Physiol CrossRef
  10. Activation of LXRβ inhibits proliferation, promotes apoptosis, and increases chemosensitivity of gastric cancer cells by upregulating the expression of ATF4
    Jie Liu et al, 2019, J Cell Biochem CrossRef
  11. A Bayesian Network Meta-Analysis for Identifying the Optimal Taxane-Based Chemotherapy Regimens for Treating Gastric Cancer
    Dan Zhang et al, 2019, Front. Pharmacol. CrossRef
  12. Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin
    Yoshinao Ohbatake et al, 2016, Clin Exp Med CrossRef
  13. Cytoskeletal signaling in TGFβ-induced epithelial-mesenchymal transition
    Sandeep M. Nalluri et al, 2015, Cytoskeleton CrossRef
  14. Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target
    Danielle Brooks et al, 2018, Oncotarget CrossRef
  15. Low-dose paclitaxel downregulates MYC proto-oncogene bHLH transcription factor expression in colorectal carcinoma cells
    Wenjing Li et al, 2017, Oncol Lett CrossRef
  16. Boosting Replication and Penetration of Oncolytic Adenovirus by Paclitaxel Eradicate Peritoneal Metastasis of Gastric Cancer
    Wataru Ishikawa et al, 2020, Molecular Therapy - Oncolytics CrossRef
  17. Mechanotransduction-targeting Drugs Attenuate Stiffness-induced Hepatic Stellate Cell Activation in vitro.
    Mutsuko Sakai et al, 2020, Biological & Pharmaceutical Bulletin CrossRef
  18. Novel therapies emerging in oncology to target the TGF-β pathway
    Byung-Gyu Kim et al, 2021, J Hematol Oncol CrossRef
  19. Cytoskeleton Reorganization in EndMT-The Role in Cancer and Fibrotic Diseases.
    Wojciech Michał Ciszewski et al, 2021, Int J Mol Sci CrossRef
  20. Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers
    Xiaoqun Lv et al, 2021, WJGO CrossRef
  21. The interactions of paclitaxel with tumour microenvironment
    Ding-Li Yu et al, 2022, International Immunopharmacology CrossRef
  22. Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights
    Kuan-Jung Chiu et al, 2022, Biomedicines CrossRef
  23. Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis after Neoadjuvant Therapy of Pancreatic Carcinoma
    Ulrike Heger et al, 2022, Cancers CrossRef
  24. Effect of paclitaxel priming on doxorubicin penetration in a multicellular layer model of human colorectal cancer cells
    Kwang-Seock Kim et al, 2023, Biochemical and Biophysical Research Communications CrossRef
  25. Low dose Taxol ameliorated renal fibrosis in mice with diabetic kidney disease by downregulation of HIPK2
    Yang Xia et al, 2023, Life Sciences CrossRef
  26. Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel
    Mário Sousa-Pimenta et al, 2023, Front. Pharmacol. CrossRef
  27. Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic Cancer
    Ghazaleh Pourali et al, 2023, CDT CrossRef
  28. Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies
    Samantha M. Ruff et al, 2024, Front. Oncol. CrossRef